These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 38047112)
1. Risk factors for central lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study. Du J; Yang Q; Sun Y; Shi P; Xu H; Chen X; Dong T; Shi W; Wang Y; Song Z; Shang X; Tian X Front Endocrinol (Lausanne); 2023; 14():1288527. PubMed ID: 38047112 [TBL] [Abstract][Full Text] [Related]
4. Predicting factors of central lymph node metastasis and BRAF Zhou SL; Guo YP; Zhang L; Deng T; Xu ZG; Ding C; Sun WC; Zhao YW; Kong LF World J Surg Oncol; 2021 Jul; 19(1):211. PubMed ID: 34256769 [TBL] [Abstract][Full Text] [Related]
5. Association of BRAF V600E Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery Centers. Han PA; Kim HS; Cho S; Fazeli R; Najafian A; Khawaja H; McAlexander M; Dy B; Sorensen M; Aronova A; Sebo TJ; Giordano TJ; Fahey TJ; Thompson GB; Gauger PG; Somervell H; Bishop JA; Eshleman JR; Schneider EB; Witwer KW; Umbricht CB; Zeiger MA Thyroid; 2016 Apr; 26(4):532-42. PubMed ID: 26950846 [TBL] [Abstract][Full Text] [Related]
6. An Online Model for Central Lymph Node Metastases in Papillary Thyroid Carcinoma With BRAF V600E Mutation. Chen H; Pan WK; Ren SY; Zhou YL Am J Clin Oncol; 2024 Aug; 47(8):383-390. PubMed ID: 38664891 [TBL] [Abstract][Full Text] [Related]
7. The synergic effect of BRAF Qu HJ; Qu XY; Hu Z; Lin Y; Wang JR; Zheng CF; Tan Z Endocr J; 2018 Jan; 65(1):113-120. PubMed ID: 29070763 [TBL] [Abstract][Full Text] [Related]
8. Predictors and a Prediction Model for Central Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma (cN0). Gao X; Luo W; He L; Cheng J; Yang L Front Endocrinol (Lausanne); 2021; 12():789310. PubMed ID: 35154002 [TBL] [Abstract][Full Text] [Related]
9. Predictors for central lymph node metastases in CN0 papillary thyroid microcarcinoma (mPTC): A retrospective analysis of 1304 cases. Zhang Q; Wang Z; Meng X; Duh QY; Chen G Asian J Surg; 2019 Apr; 42(4):571-576. PubMed ID: 30348606 [TBL] [Abstract][Full Text] [Related]
10. BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer. Howell GM; Nikiforova MN; Carty SE; Armstrong MJ; Hodak SP; Stang MT; McCoy KL; Nikiforov YE; Yip L Ann Surg Oncol; 2013 Jan; 20(1):47-52. PubMed ID: 22941165 [TBL] [Abstract][Full Text] [Related]
11. A prediction model incorporating the BRAF Liu S; Liu C; Zhao L; Wang K; Li S; Tian Y; Jiao B; Gui Z; Yu T; Zhang L Eur J Surg Oncol; 2021 Nov; 47(11):2774-2780. PubMed ID: 34483032 [TBL] [Abstract][Full Text] [Related]
12. Role of BRAF V600E mutation as an indicator of the extent of thyroidectomy and lymph node dissection in conventional papillary thyroid carcinoma. Kim SK; Woo JW; Lee JH; Park I; Choe JH; Kim JH; Kim JS Surgery; 2015 Dec; 158(6):1500-11. PubMed ID: 26120069 [TBL] [Abstract][Full Text] [Related]
13. [Study on the correlation between BRAF(V600E) mutation and lymphatic metastases in papillary thyroid cancer staged preoperativelv as N0]. Gao Q; Zhang W; Wang N; Duan H; Zhou Y; Zhang W; Zhao D Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Dec; 29(23):2048-52. PubMed ID: 27101676 [TBL] [Abstract][Full Text] [Related]
14. Predictive Value of Ultrasound Imaging Characteristics and a BRAF V600E Nomogram for Central Lymph Node Metastasis Risk in Papillary Thyroid Microcarcinoma. Zhu D; Wu X; Zhang L; Chen Z Altern Ther Health Med; 2023 Nov; 29(8):139-143. PubMed ID: 37632946 [TBL] [Abstract][Full Text] [Related]
15. Conventional Ultrasound, Immunohistochemical Factors and BRAF Chen J; Li XL; Zhao CK; Wang D; Wang Q; Li MX; Wei Q; Ji G; Xu HX Ultrasound Med Biol; 2018 Nov; 44(11):2296-2306. PubMed ID: 30100099 [TBL] [Abstract][Full Text] [Related]
16. The Impact of Coexistent Hashimoto's Thyroiditis on Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma. Liu Y; Lv H; Zhang S; Shi B; Sun Y Front Endocrinol (Lausanne); 2021; 12():772071. PubMed ID: 34867817 [TBL] [Abstract][Full Text] [Related]
17. Preoperative prediction of central lymph node metastasis in cN0T1/T2 papillary thyroid carcinoma: A nomogram based on clinical and ultrasound characteristics. Li J; Sun P; Huang T; Li L; He S; Ai X; Xiao H; Xue G Eur J Surg Oncol; 2022 Jun; 48(6):1272-1279. PubMed ID: 35414404 [TBL] [Abstract][Full Text] [Related]
18. Association between diffuse lymphocytic infiltration and papillary thyroid cancer aggressiveness according to the presence of thyroid peroxidase antibody and BRAF Lee YK; Park KH; Park SH; Kim KJ; Shin DY; Nam KH; Chung WY; Lee EJ Head Neck; 2018 Oct; 40(10):2271-2279. PubMed ID: 29935011 [TBL] [Abstract][Full Text] [Related]
19. [Association between BRAF V600E mutation and central lymph node metastasis in patients with papillary thyroid carcinoma]. Shi C; Qin H; Ding C; Sun Y; Lyu Y; Shi T Zhonghua Zhong Liu Za Zhi; 2015 Feb; 37(2):123-7. PubMed ID: 25975689 [TBL] [Abstract][Full Text] [Related]
20. Risk factors for predicting central lymph node metastasis in papillary thyroid microcarcinoma (CN0): a study of 273 resections. Li M; Zhu XY; Lv J; Lu K; Shen MP; Xu ZL; Wu ZS Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3801-3807. PubMed ID: 28975988 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]